Subcommittee on Procedures Reviews, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 1689-1690 [E9-524]
Download as PDF
<![CDATA[
1689
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
that each assisted reproductive
technology (ART) program shall
annually report to the Secretary through
the Centers for Disease Control and
Prevention: (1) Pregnancy success rates
achieved by such ART program, and (2)
the identity of each embryo laboratory
used by such ART program and whether
the laboratory is certified or has applied
for such certification under the Act. The
required information is currently
reported by ART programs to CDC as
specified in the Assisted Reproductive
Technology (ART) Program Reporting
System (OMB No. 0920–0556, exp. 9/
30/2009). CDC seeks to extend OMB
approval for a period of three years and
incorporate a minor change in wording
to one question. In addition, the revised
total burden estimate includes an
anticipated increase in the number of
respondents and a slight decrease in the
average number of responses per
respondent. The burden estimate per
response has also been revised to
include an adjustment for data
validation procedures.
The currently approved program
reporting system, also known as the
National ART Surveillance System
(NASS), includes information about all
ART cycles initiated by any of the ART
programs in the United States. An ART
cycle is considered to begin when a
woman begins taking ovarian
stimulatory drugs or starts ovarian
monitoring with the intent of having
embryos transferred. The system also
collects information about the
pregnancy outcome of each cycle, as
well as a number of data items deemed
important to explain variability in
success rates across ART programs and
across individuals. Data elements and
definitions currently in use reflect
CDC’s consultations with
representatives of the Society for
Assisted Reproductive Technology
(SART), the American Society for
Reproductive Medicine, and RESOLVE,
the National Infertility Association (a
national, nonprofit consumer
organization), as well as a variety of
individuals with expertise and interest
in this field.
Respondents are the 480 ART
programs in the United States.
Approximately 420 clinics are expected
to report an average of 286 ART cycles
each. Ten percent of responding clinics
will be randomly selected to participate
in full validation of selected ART cycle
records and an abbreviated validation of
selected cycles resulting in live birth.
All information is collected
electronically. Respondents have the
option of entering data directly into a
Web-based NASS interface or of
transmitting system-compatible files
extracted from other record systems.
The ART program reporting system
allows CDC to publish an annual report
to Congress as specified by the FCSRCA
and to provide information needed by
consumers.
There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Respondents
Form name
ART Programs ......................................
Number of
respondents
NASS ....................
Dated: January 2, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–405 Filed 1–12–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee on Procedures
Reviews, Advisory Board on Radiation
and Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention, announces the
following meeting for the
aforementioned subcommittee:
Time and Date: 9:30 a.m.–5 p.m., January
28, 2009.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859) 334–4611, Fax (859) 334–
4619.
Status: Open to the public, but without a
public comment period. To access by
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
Number of
responses per
respondent
420
286
conference call dial the following
information 1(866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2009.
Purpose: The Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Average burden
per response
(in hours)
38/60
Total burden
(in hours)
76,076
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee on Procedures
Reviews was established to aid the Advisory
Board in carrying out its duty to advise the
Secretary, HHS, on dose reconstruction. It
will be responsible for overseeing, tracking,
and participating in the reviews of all
procedures used in the dose reconstruction
process by the NIOSH Office of
Compensation Analysis and Support (OCAS)
and its dose reconstruction contractor.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes: a
discussion of proposed new versions of the
computer-assisted telephone interview
scripts and procedures NIOSH uses to
interview claimants at the outset of the dose
reconstruction process; a discussion of
ORAUT–OTIB–0054 (‘‘Fission and
Activation Product Assignment for Internal
Dose-Related Gross Beta and Gross Gamma
Analyses’’) and ORAUT–OTIB–0066
(‘‘Calculation of Dose from Intakes of Special
Tritium Compounds’’); and, a continuation of
the comment-resolution process for other
dose reconstruction procedures under review
by the Subcommittee.
E:\FR\FM\13JAN1.SGM
13JAN1
1690
Federal Register / Vol. 74, No. 8 / Tuesday, January 13, 2009 / Notices
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, Mailstop E–20,
Atlanta, Georgia 30333, Telephone (513)
533–6800, Toll Free 1 (800) CDC–INFO, email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: January 7, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–524 Filed 1–12–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Child Care Quarterly Case
Record Report—ACF–801.
OMB No.: 0970–0167.
Description: Section 658K of the Child
Care and Development Block Grant Act
of 1990 (Pub. L. 101–508, 42 U.S.C.
9858) requires that States and
Territories submit monthly case-level
data on the children and families
receiving direct services under the Child
Care and Development Fund. The
implementing regulations for the
statutorily required reporting are at 45
CFR 98.70. Case-level reports, submitted
quarterly or monthly (at grantee option),
include monthly sample or full
population case-level data. The data
elements to be included in these reports
are represented in the ACF–801. ACF
uses disaggregate data to determine
program and participant characteristics
as well as costs and levels of child care
services provided. This provides ACF
with the information necessary to make
reports to Congress, address national
child care needs, offer technical
assistance to grantees, meet performance
measures, and conduct research.
Consistent with the statute and
regulations, ACF requests extension of
the ACF–801. With this extension, ACF
is proposing several changes and
clarifications to the reporting
requirements and instructions.
Respondents: States, the District of
Columbia, and Territories including
Puerto Rico, Guam, the Virgin Islands,
American Samoa, and the Northern
Mariana Islands.
ANNUAL BURDEN ESTIMATES
Number
of respondents
Instrument
ACF–801 ..........................................................................................................................................
Estimated Total Annual Burden
Hours: 4,480
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
VerDate Nov<24>2008
19:10 Jan 12, 2009
Jkt 217001
Dated: January 8, 2009.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E9–447 Filed 1–12–09; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–N–0038]
Advisory Committees; Tentative
Schedule of Meetings for 2009
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
tentative schedule of forthcoming
meetings of its public advisory
committees for 2009. During 1991, at the
request of the Commissioner of Food
and Drugs (the Commissioner), the
Institute of Medicine (the IOM)
conducted a study of the use of FDA’s
advisory committees. In its final report,
one of the IOM’s recommendations was
for the agency to publish an annual
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Number
of responses
per respondent
Average
burden
hours per
response
Total burden hours
4
20
4,480
56
tentative schedule of its meetings in the
Federal Register. This publication
implements the IOM’s recommendation.
FOR FURTHER INFORMATION CONTACT:
Theresa L. Green, Advisory Committee
Oversight and Management Staff (HF–
4), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,
301–827–1220.
SUPPLEMENTARY INFORMATION: The IOM,
at the request of the Commissioner,
undertook a study of the use of the
FDA’s advisory committees. In its final
report in 1992, one of the IOM’s
recommendations was for FDA to adopt
a policy of publishing an advance yearly
schedule of its upcoming public
advisory committee meetings in the
Federal Register; FDA has implemented
this recommendation. The annual
publication of tentatively scheduled
advisory committee meetings will
provide both advisory committee
members and the public with the
opportunity, in advance, to schedule
attendance at FDA’s upcoming advisory
committee meetings. Because the
schedule is tentative, amendments to
this notice will not be published in the
Federal Register. However, changes to
the schedule will be posted on the FDA
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 74, Number 8 (Tuesday, January 13, 2009)]
[Notices]
[Pages 1689-1690]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-524]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee on Procedures Reviews, Advisory Board on Radiation
and Worker Health (ABRWH), National Institute for Occupational Safety
and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention, announces the following meeting for the aforementioned
subcommittee:
Time and Date: 9:30 a.m.-5 p.m., January 28, 2009.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018. Telephone (859) 334-4611, Fax (859) 334-4619.
Status: Open to the public, but without a public comment period.
To access by conference call dial the following information 1(866)
659-0537, Participant Pass Code 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
that have been promulgated by the Department of Health and Human
Services (HHS) as a final rule; advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2009.
Purpose: The Advisory Board is charged with (a) Providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class. The Subcommittee on Procedures Reviews was established
to aid the Advisory Board in carrying out its duty to advise the
Secretary, HHS, on dose reconstruction. It will be responsible for
overseeing, tracking, and participating in the reviews of all
procedures used in the dose reconstruction process by the NIOSH
Office of Compensation Analysis and Support (OCAS) and its dose
reconstruction contractor.
Matters To Be Discussed: The agenda for the Subcommittee meeting
includes: a discussion of proposed new versions of the computer-
assisted telephone interview scripts and procedures NIOSH uses to
interview claimants at the outset of the dose reconstruction
process; a discussion of ORAUT-OTIB-0054 (``Fission and Activation
Product Assignment for Internal Dose-Related Gross Beta and Gross
Gamma Analyses'') and ORAUT-OTIB-0066 (``Calculation of Dose from
Intakes of Special Tritium Compounds''); and, a continuation of the
comment-resolution process for other dose reconstruction procedures
under review by the Subcommittee.
[[Page 1690]]
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
Contact Person for More Information: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO,
e-mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: January 7, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-524 Filed 1-12-09; 8:45 am]
BILLING CODE 4163-18-P
